Acquired retinoschisis resolved after 23Gage pars plana vitrectomy in posterior microphthalmos
© Yu et al.; licensee BioMed Central Ltd. 2014
Received: 23 January 2014
Accepted: 7 May 2014
Published: 11 May 2014
Posterior microphthalmos combined with acquired retinoschisis is a rare entity. This report presents a case of acquired retinoschisis in a patient with posterior microphthalmos and discusses the management for such disease. The patient exhibited acquired peripheral retinal schisis in both eyes.
The patient presented with a fix scotoma and decrease in visual acuity for 2 weeks in his left eye. Ocular examination revealed that his best-corrected visual acuity was 0.6 in right eye and 0.2 in left eye. The patient had amblyopia because of hyperopia with spherical equivalent of +11.75 diopters in the right eye and +12.00 diopters in the left eye. The axial lengths were 18.41 mm in right and 18.43 mm in left eyes respectively. Slip lamp examination found normal anterior segments. Funduscopy showed bilateral retinoschisis in inferotemporal retina. The schisis in right eye was limited to peripheral retina whereas the schisis in left eye was bullous type. The schisis in the left eye extended from the periphery to the posterior macular region in left eye. A pars plana vitrectomy was performed in the left eye and visual acuity was restored to 0.6.
Posterior microphthalmos combined with retinoschisis is rare. When it appears in peripheral retina, the schisis remains stable. In cases where the schisis extends to posterior pole and affects the macula, surgery in the form of pars plana vitrectomy could be an option.
KeywordsMicrophthalmos Acquired retinoschisis Pars plana vitrectomy
Posterior microphthalmos (PM) is a developmental defect in which affected eyes display vitreous chamber foreshortening, and papillomacular retinal folds with normal or nearly normal anterior chamber depth, . PM is a relatively rare. It usually coexists with high hyperopia, glaucoma, uveal effusion syndrome, and exudative retinal detachment [2, 3]. PM combined with foveoschisis has been reported in some cases [4, 5] and has been related to gene mutation [4, 6]. Prevously, schisis has been reported in 3 cases with nanophthalmos , in which the schisis was limited to the peripheral retina. We present a case with PM and bullous-like retinoschisis in a hyperopic eye.
Spectralis optical coherence tomography (OCT) scan showed a thick retinaal neurosensory layer and a thick choroid (503 μm) in right eye (Figure 1F). In left eye, the schisis was too high to obtain an image (Figure 1G).
In order to exclude retinoschisis related to possible inflammation, a short-term course of systemic corticosteroids was used. Methylprednisolone was started at a dose of 1.6 mg/kg/day for 3 days, followed by 0.8 mg/kg/day for 3 days and 0.4 mg/kg/day for 5 days. However, the bulla showed no change. Next, we performed 23 G pars plana vitrectomy in the left eye. Before surgery, a careful scleral depression examination was performed to rule out any outer or inner layer breaks of retina. Triamcinolone acetonide associated posterior vitreous detachment was performed. After an internal drainage hole was made, the bulla collapsed. This was followed by photocoagulation in schisis region under perfluorocarbon liquid. This was followed by tamponade with C3F8.
Foveoschisis in nanothalmols or in PM has been reported. While previous reports present foveoschisis that was always combined with RPE abnormalities, or papillomacular folds caused by microphthalmos [1, 4], in our case there were no signs of RPE abnormalities, or foveoschisis. Similar retinal findings have been described in association with nanophthalmos by Dhrami-Gavazi et al. in 2009 . However, in his three cases, the schisis was just localized in peripheral. Paplliomacular folds are common in posterior nanophthalmos because of scleral growth independent of neuroretinal growth [1–3]. In our case, macular folds in left eye resulted due to cmprssion by bullous-like schisis. The macular was normal in the fellow eye.
Uveal effusion syndrome (UEF) and glaucoma have been reported to be very common in nanophthalmos. There were no symptoms of UEF in our case, such as cililary body detachment, leopard-spot in FFA, and retinal detachment. The eyes with nanophthalmos have thick sclera, uvea, and retina which may contribute to the irregular outflow of the eye, which causes the cystic dengeneration of the retina.
The management of our case was very challenging. According to our long-term observation of X-linked retinoschisis, in 82% (9 out of 11 eyes) of the eyes the schisis or retinal detachment progressed and visual acuity decreased during a mean follow-up of 34.7 months . In vitrectomy group (n = 17 eyes), foveoschisis resolved in all eyes with resolution of retinal detachment in 94% (16 out of 17 eyes) of the eyes with recovery of visual acuity. Vitrectomy may be an effective and essential treatment for patients with progressive X-linked retinoschisis to prevent deterioration of vision. Though the mechanism is different between X-linked retinoschisis and acquired retinoschisis, the schisis in our case extended to posterior retina and visual acuity decreased. The outcome after surgery proved that vitrectomy is effective for preventing the schisis progression and deterioration of visual acuity.
In conclusion, in this rare case we found that if schisis is limited to the peripheral retina it may be stable but, if it progressed to the posterior pole, vitrectomy may prevent the progression of acquired retinoschisis.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
Best correct visual acuity
Uveal effusion syndrome
Optical coherence tomography.
This work was supported by the Specialized Research Foundation for Doctoral Program of Higher Education (no. 20120171110086).
- Spitznas M, Gerke E, Bateman JB: Hereditary posterior microphthalmos with papillomacular fold and high hyperopia. Arch Ophthalmol. 1983, 101 (3): 413-417. 10.1001/archopht.1983.01040010413014.View ArticlePubMedGoogle Scholar
- Khairallah M, Messaoud R, Zaouali S, Ben Yahia S, Ladjimi A, Jenzri S: Posterior segment changes associated with posterior microphthalmos. Ophthalmology. 2002, 109 (3): 569-574. 10.1016/S0161-6420(01)00996-4.View ArticlePubMedGoogle Scholar
- Slotnick S, Fitzgerald DE, Sherman J, Krumholz DM: Pervasive ocular anomalies in posterior microphthalmos. Optometry. 2007, 78 (2): 71-77. 10.1016/j.optm.2006.08.016.View ArticlePubMedGoogle Scholar
- Pehere N, Jalali S, Deshmukh H, Kannabiran C: Posterior microphthalmos pigmentary retinopathy syndrome. Doc Ophthalmol. 2011, 122 (2): 127-132. 10.1007/s10633-011-9266-1.View ArticlePubMedGoogle Scholar
- Sonmez K, Ozcan PY: Angle-closure glaucoma in a patient with the nanophthalmos-ocular cystinosis-foveoschisis-pigmentary retinal dystrophy complex. BMC Ophthalmol. 2012, 12: 23-10.1186/1471-2415-12-23.View ArticlePubMedPubMed CentralGoogle Scholar
- Aldahmesh MA, Nowilaty SR, Alzahrani F, Al-Ebdi L, Mohamed JY, Rajab M, Khan AO, Alkuraya FS: Posterior microphthalmos as a genetically heterogeneous condition that can be allelic to nanophthalmos. Arch Ophthalmol. 2011, 129 (6): 805-820.View ArticlePubMedGoogle Scholar
- Dhrami-Gavazi E, Schiff WM, Barile GR: Nanophthalmos and acquired retinoschisis. Am J Ophthalmol. 2009, 147: 108-110. 10.1016/j.ajo.2008.07.045.View ArticlePubMedGoogle Scholar
- Sundin OH, Leppert GS, Silva ED, Yang JM, Dharmaraj S, Maumenee IH, Santos LC, Parsa CF, Traboulsi EI, Broman KW, Dibernardo C, Sunness JS, Toy J, Weinberg EM: Extreme hyperopia is the result of null mutations in MFRP, which encodes a Frizzled-related protein. Proc Natl Acad Sci U S A. 2005, 102 (27): 9553-9558. 10.1073/pnas.0501451102.View ArticlePubMedPubMed CentralGoogle Scholar
- Yu H, Li T, Luo Y, Yu S, Li S, Lei L, Li J, Ding X, Yuan L, Tang S: Long-term outcomes of vitrectomy for progressive X-linked retinoschisis. Am J Ophthalmol. 2012, 154 (2): 394-402. 10.1016/j.ajo.2012.02.005.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2415/14/65/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.